UA31257U - Способ оценки эффективности коррекции нарушений липидного обмена энтеросгелем - Google Patents
Способ оценки эффективности коррекции нарушений липидного обмена энтеросгелем Download PDFInfo
- Publication number
- UA31257U UA31257U UAU200801101U UAU200801101U UA31257U UA 31257 U UA31257 U UA 31257U UA U200801101 U UAU200801101 U UA U200801101U UA U200801101 U UAU200801101 U UA U200801101U UA 31257 U UA31257 U UA 31257U
- Authority
- UA
- Ukraine
- Prior art keywords
- enterosgel
- correction
- effectiveness
- liver
- disorder
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 25
- 238000012937 correction Methods 0.000 title claims abstract description 12
- 238000011156 evaluation Methods 0.000 title abstract description 3
- 125000003473 lipid group Chemical group 0.000 title 1
- 241000700159 Rattus Species 0.000 claims abstract description 12
- 150000002632 lipids Chemical group 0.000 claims abstract description 8
- 210000003470 mitochondria Anatomy 0.000 claims abstract description 6
- 210000004185 liver Anatomy 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims abstract description 5
- 238000001030 gas--liquid chromatography Methods 0.000 claims abstract description 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 6
- 229930195729 fatty acid Natural products 0.000 claims description 6
- 239000000194 fatty acid Substances 0.000 claims description 6
- 150000004665 fatty acids Chemical class 0.000 claims description 6
- 208000017170 Lipid metabolism disease Diseases 0.000 claims description 3
- 210000001589 microsome Anatomy 0.000 claims description 2
- 238000012876 topography Methods 0.000 claims 1
- 238000010606 normalization Methods 0.000 abstract description 3
- 239000002253 acid Substances 0.000 abstract 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 8
- 210000005229 liver cell Anatomy 0.000 description 5
- 230000003228 microsomal effect Effects 0.000 description 5
- 239000002676 xenobiotic agent Substances 0.000 description 5
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 231100000572 poisoning Toxicity 0.000 description 4
- 230000000607 poisoning effect Effects 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 3
- 230000003859 lipid peroxidation Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- SZIFAVKTNFCBPC-UHFFFAOYSA-N 2-chloroethanol Chemical compound OCCCl SZIFAVKTNFCBPC-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000001631 haemodialysis Methods 0.000 description 2
- 230000000322 hemodialysis Effects 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010037211 Psychomotor hyperactivity Diseases 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000007321 biological mechanism Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 231100000313 clinical toxicology Toxicity 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000001085 differential centrifugation Methods 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000001719 hemosorption Effects 0.000 description 1
- 239000003845 household chemical Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 210000001700 mitochondrial membrane Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000001050 pharmacotherapy Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 231100000816 toxic dose Toxicity 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000002034 xenobiotic effect Effects 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Способ оценки эффективности коррекции нарушений липидного обмена энтеросгелем состоит в том, что методом газожидкостной хроматографии определяют изменения жирнокислотного состава липидов структурных элементов печени (митохондрий и микросом) отравленных крыс после применения энтеросгеля на протяжении 7 дней, полученные результаты сравнивают с контролем и при нормализации показателей оценивают эффективность коррекции.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU200801101U UA31257U (ru) | 2008-01-30 | 2008-01-30 | Способ оценки эффективности коррекции нарушений липидного обмена энтеросгелем |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU200801101U UA31257U (ru) | 2008-01-30 | 2008-01-30 | Способ оценки эффективности коррекции нарушений липидного обмена энтеросгелем |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA31257U true UA31257U (ru) | 2008-03-25 |
Family
ID=39818852
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU200801101U UA31257U (ru) | 2008-01-30 | 2008-01-30 | Способ оценки эффективности коррекции нарушений липидного обмена энтеросгелем |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA31257U (ru) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2473346C1 (ru) * | 2011-07-18 | 2013-01-27 | Государственное бюджетное образовательное учреждение высшего профессионального образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО Первый МГМУ им. И.М. Сеченова Минздравсоцразвити | Способ лечения лекарственно-индуцированного поражения печени у детей, больных туберкулезом легких |
-
2008
- 2008-01-30 UA UAU200801101U patent/UA31257U/ru unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2473346C1 (ru) * | 2011-07-18 | 2013-01-27 | Государственное бюджетное образовательное учреждение высшего профессионального образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО Первый МГМУ им. И.М. Сеченова Минздравсоцразвити | Способ лечения лекарственно-индуцированного поражения печени у детей, больных туберкулезом легких |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Busquets-Garcia et al. | Pregnenolone blocks cannabinoid-induced acute psychotic-like states in mice | |
| Perrine et al. | Severe, multimodal stress exposure induces PTSD-like characteristics in a mouse model of single prolonged stress | |
| Allen et al. | Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis | |
| Ishankhodjaev et al. | Study on Effects of Liposomal Quercetin on Biochemical Parameters of the Nigrostriatal System of Rats with Experimentally Induced Neurodegenerative Disease | |
| Nelms et al. | Development of an in silico profiler for mitochondrial toxicity | |
| Calabrese et al. | Hormesis, cellular stress response and neuroinflammation in schizophrenia: Early onset versus late onset state | |
| Ahsan et al. | Naringenin upregulates AMPK-mediated autophagy to rescue neuronal cells from β-amyloid (1–42) evoked neurotoxicity | |
| Chattopadhyay et al. | Lipid–protein interactions, regulation and dysfunction of brain cholesterol | |
| Aki et al. | Impairment of autophagy: from hereditary disorder to drug intoxication | |
| Han et al. | Sestrin2 protects against cholestatic liver injury by inhibiting endoplasmic reticulum stress and NLRP3 inflammasome-mediated pyroptosis | |
| Pouladi et al. | NP03, a novel low-dose lithium formulation, is neuroprotective in the YAC128 mouse model of Huntington disease | |
| Feng et al. | Enantioselectivity of 2, 2′, 3, 5′, 6-pentachlorobiphenyl (PCB 95) atropisomers toward ryanodine receptors (RyRs) and their influences on hippocampal neuronal networks | |
| Haremaki et al. | Huntingtin is required for ciliogenesis and neurogenesis during early Xenopus development | |
| Gutierrez et al. | A novel AhR ligand, 2AI, protects the retina from environmental stress | |
| Blaževski et al. | Betulinic acid regulates generation of neuroinflammatory mediators responsible for tissue destruction in multiple sclerosis in vitro | |
| Cheng et al. | Minocycline, a classic antibiotic, exerts psychotropic effects by normalizing microglial neuroinflammation-evoked tryptophan-kynurenine pathway dysregulation in chronically stressed male mice | |
| Edwards et al. | Sphingolipids and ceramides of mouse aqueous humor: Comparative profiles from normotensive and hypertensive DBA/2J mice | |
| US8980884B2 (en) | Methods for treating Alzheimer's disease | |
| Handl et al. | Effects of charged oxime reactivators on the HK-2 cell line in renal toxicity screening | |
| Bach et al. | Chronic ethanol exposures leads to a negative affective state in female rats that is accompanied by a paradoxical decrease in ventral hippocampus excitability | |
| Ma et al. | Mitocytosis is critical for phthalate-induced injury to the ovarian granulosa cell layer in quail (Coturnix japonica) | |
| UA31257U (ru) | Способ оценки эффективности коррекции нарушений липидного обмена энтеросгелем | |
| Gallegos et al. | Behavioral and neurochemical impairments after intranasal administration of chlorpyrifos formulation in mice | |
| Schierwagen et al. | Pathogenetic mechanisms and therapeutic approaches of acute-to-chronic liver failure | |
| Halberstadt et al. | Habituation and sensitization of acoustic startle: opposite influences of dopamine D1 and D2-family receptors |